SEC Form 4 · accession 0001127602-16-054483
GILEAD SCIENCES, INC. · GILD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Paul Rutherford Carter
Officer — EVP Commercial Ops
Period of report
May 31, 2016
Accepted (ET)
Jun 2, 2016 · 4:35 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000882095
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 31, 2016 | M | 43,200 | $24.295 | A | 104,322 | D | |
| Common Stock | May 31, 2016 | M | 4,232 | $24.905 | A | 108,554 | D | |
| Common Stock | May 31, 2016 | M | 5,795 | $80.65 | A | 114,349 | D | |
| Common Stock | May 31, 2016 | M | 3,865 | $80.65 | A | 118,214 | D | |
| Common StockF4 | May 31, 2016 | S | 57,092 | $86.8528 | D | 61,122 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-qualified Stock Option (Right to Buy)F2 | $24.295 | May 31, 2016 | M | 43,200 | D | — | Jan 26, 2022 | Common Stock | 43,200 | 0 | D |
| Non-qualified Stock Option (Right to Buy)F3 | $24.905 | May 31, 2016 | M | 4,232 | D | — | Jul 29, 2019 | Common Stock | 4,232 | 30,226 | D |
| Non-qualified Stock Option (Right to Buy)F2 | $80.65 | May 31, 2016 | M | 5,795 | D | — | Feb 1, 2024 | Common Stock | 5,795 | 0 | D |
| Non-qualified Stock Option (Right to Buy)F2 | $80.65 | May 31, 2016 | M | 3,865 | D | — | Feb 1, 2024 | Common Stock | 3,865 | 16,906 | D |
Explanation of responses
- F1The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan.
- F2The options have a four year vesting schedule. 25% of the options will vest on the first anniversary date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested.
- F3The options have a five year vesting schedule. 20% vest on the first anniversary of the date of grant. The balance will vest 5% quarterly thereafter until fully vested.
- F4Sale prices reported for the transactions reported here range from $86.6075 to $87.1008. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.